Healthcare provider profile · identity verified

Ravi Kumar Sreerama, M.D.

Internal Medicine · CLARKSVILLE, TX · NPI 1154373397

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	229	79
Amlodipine Besylate	Amlodipine Besylate	217	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	216	51
Furosemide	Furosemide	197	70
Gabapentin	Gabapentin	192	68
Albuterol Sulfate Hfa	Albuterol Sulfate	160	52
Losartan Potassium	Losartan Potassium	158	62
Pantoprazole Sodium	Pantoprazole Sodium	131	52
Metformin Hcl	Metformin Hcl	120	54
Trazodone Hcl	Trazodone Hcl	118	50
Tizanidine Hcl	Tizanidine Hcl	107	51
Azithromycin	Azithromycin	105	68
Lisinopril	Lisinopril	101	38
Alprazolam	Alprazolam	99	27
Levothyroxine Sodium	Levothyroxine Sodium	97	44
Meloxicam	Meloxicam	95	44
Hydrochlorothiazide	Hydrochlorothiazide	91	42
Tamsulosin Hcl	Tamsulosin Hcl	90	31
Omeprazole	Omeprazole	89	26
Carvedilol	Carvedilol	88	39
Eliquis	Apixaban	87	26
Tramadol Hcl	Tramadol Hcl	87	34
Diclofenac Sodium	Diclofenac Sodium	86	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	80	43
Hydralazine Hcl	Hydralazine Hcl	74	29
Potassium Chloride	Potassium Chloride	74	30
Simvastatin	Simvastatin	69	30
Donepezil Hcl	Donepezil Hcl	68	29
Metoprolol Tartrate	Metoprolol Tartrate	65	24
Montelukast Sodium	Montelukast Sodium	65	26
Promethazine Hcl	Promethazine Hcl	64	16
Glipizide	Glipizide	61	28
Methylprednisolone	Methylprednisolone	60	42
Clonazepam	Clonazepam	59	19
Citalopram Hbr	Citalopram Hydrobromide	54	20
Prednisone	Prednisone	54	18
Triamcinolone Acetonide	Triamcinolone Acetonide	51	16
Metoprolol Succinate	Metoprolol Succinate	50	23
Clopidogrel	Clopidogrel Bisulfate	48	20
Fluticasone Propionate	Fluticasone Propionate	46	16
Megestrol Acetate	Megestrol Acetate	46	15
Quetiapine Fumarate	Quetiapine Fumarate	44	13
Zolpidem Tartrate	Zolpidem Tartrate	43	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	26
Ventolin Hfa	Albuterol Sulfate	42	11
Amoxicillin	Amoxicillin	40	28
Propranolol Hcl	Propranolol Hcl	39	13
Vitamin D2	Ergocalciferol (Vitamin D2)	37	17
Acetaminophen-Codeine	Acetaminophen With Codeine	35	13
Januvia	Sitagliptin Phosphate	35	16
Latanoprost	Latanoprost	35	suppressed
Allopurinol	Allopurinol	34	14
Xarelto	Rivaroxaban	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	15
Lidocaine	Lidocaine	32	12
Nifedipine Er	Nifedipine	32	suppressed
Lactulose	Lactulose	30	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Ozempic	Semaglutide	29	suppressed
Finasteride	Finasteride	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Spironolactone	Spironolactone	27	13
Alendronate Sodium	Alendronate Sodium	26	12
Clonidine Hcl	Clonidine Hcl	26	suppressed
Nystatin	Nystatin	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	11
Ibuprofen	Ibuprofen	24	11
Baclofen	Baclofen	23	11
Levetiracetam	Levetiracetam	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Metronidazole	Metronidazole	23	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	13
Methocarbamol	Methocarbamol	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	11
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Famotidine	Famotidine	20	11
Glipizide Er	Glipizide	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Haloperidol	Haloperidol	17	suppressed
Constulose	Lactulose	16	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Linzess	Linaclotide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Prolia	Denosumab	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Desoximetasone	Desoximetasone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Atenolol	Atenolol	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error